source
- FDA approves Lilly's once-weekly basal insulin Onswik for adults with type 2 diabetesThe U.S. Food and Drug Administration has granted approval to Eli Lilly’s Onswik, a basal insulin designed for once-weekly injection in adults with type 2 diabetes. The new formulation offers patie…
- UN-backed agency secures sub-licensing deals for generic Roche flu drug across 129 low- and middle-income countriesAn agency supported by the United Nations has finalized sub-licensing contracts with eleven drug manufacturers to create generic versions of Roche’s influenza medication Xofluza. The agreements al…